Apart from being a single center study with a small number of patients, this study was limited by lack of data about ratio of patients with uncontrolled diabetes or anemia, as well as use of supplemental testosterone or hormone replacement therapy (HRT) such as PDE5 inhibitors and estrogen. Here, PDE5A is linked to anemia (phenotype).